Cargando…
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)
BACKGROUND: In recent years, systemic chemotherapy and molecular targeted therapy have become standard first-line treatments for locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC). The objective of this survey was to investigate first-line anticancer treatment patterns and...
Autores principales: | Zhou, Qing, Song, Yong, Zhang, Xin, Chen, Gong-Yan, Zhong, Dian-Sheng, Yu, Zhuang, Yu, Ping, Zhang, Yi-Ping, Chen, Jian-Hua, Hu, Yi, Feng, Guo-Sheng, Song, Xia, Shi, Qiang, Yang, Lu Lu, Zhang, Ping Hai, Wu, Yi-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496179/ https://www.ncbi.nlm.nih.gov/pubmed/28673332 http://dx.doi.org/10.1186/s12885-017-3451-x |
Ejemplares similares
-
Capitulaciones colombinas (1492-1506) /
por: Fernández, Rafael Diego
Publicado: (1987) -
1506. Outcomes of Standardized Neonatal Cephalexin Dosing
por: Robertson, Melena J, et al.
Publicado: (2019) -
Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study
por: Shi, Yuankai, et al.
Publicado: (2022) -
Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV)
por: Xu, Chong-Rui, et al.
Publicado: (2023) -
Poor prognosis of intra‐tumoural TRBV6‐6 variants in EGFR‐mutant NSCLC: Results from the ADJUVANT‐CTONG1104 trial
por: Chen, Cunte, et al.
Publicado: (2022)